We recognise that mitigating against & adapting to climate change is a global issue that needs multi-stakeholder collaboration.
We are working with multiple partners, including our industry bodies – the Association of the British Pharmaceutical Industry (ABPI) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) – to meet this challenge together.
We recognise that we do not have all the answers and will need to implement many solutions to fulfil the Business Ambition for 1.5ºC. We will continue to work in partnership, using the power of science to truly change lives for the better.
As a company with a global presence, we are committed to making a difference in local communities and the world around us.
We leverage scientific innovation to reduce our environmental impact through climate impact mitigation, conservation of resources and the reduction of waste.